跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
戴 荣继
生命学院
h-index
2902
引用
28
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1994 …
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(240)
相似学者
(1)
指纹图谱
深入其中 Rongji Dai 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Chemistry
Cyclodextrin
100%
Silicon Dioxide
51%
Capillary Gas Chromatography
24%
High-Pressure Liquid Chromatography
20%
Liquid Crystal
19%
Mobile Phase Composition
17%
Phenol
15%
High Performance Liquid Chromatography
15%
Polysiloxane
14%
Crown Ether
14%
Glycoside
14%
Electrospray Ionization
14%
Capillary Electrochromatography
14%
Water Soluble
14%
Gas Chromatographic Stationary Phase
13%
Bioactivity
12%
Amino Group
11%
Buffer Solution
10%
Atom Transfer Radical Polymerization
10%
Aromatic Compound
10%
Chirality in Separations
9%
4-Nitrophenol
9%
Capillar Electrophoresis
9%
Pregnane
9%
High Performance Liquid Chromatography
9%
Adenosine
9%
1H-Imidazole
9%
Tandem Mass Spectrometry
9%
N-Benzoyl-L-Arginine
9%
Pyrolysis Gas Chromatography
9%
Triterpenoid Saponin
9%
Retention Time
9%
Flow Kinetics
8%
Fourier Transform Infrared Spectroscopy
8%
Diol
7%
Separation Method
7%
Chemistry
7%
Elemental Analysis
7%
Thermogravimetric Analysis
7%
Boronate
6%
Enantiomer
6%
Boric Acid
6%
Number
6%
Gas Chromatography
6%
Structure
5%
Aqueous Solution
5%
Material Science
Silicon Dioxide
52%
High Performance Liquid Chromatography
20%
Liquid Crystal
19%
Chromatography
16%
Mobile Phase Composition
15%
Polysiloxane
14%
Electrophoretic Technology
12%
Peroxidase
12%
Polymerization
10%
Copolymer
9%
Capillary Electrochromatography
9%
Gas Chromatography
9%
Nanoparticle
9%
Hydrogel
9%
Silica Gel
9%
Enantiomer
9%
X-Ray Diffraction
8%
Scanning Electron Microscopy
7%
Mesoporous Material
7%
Atom-Transfer Radical-Polymerization
7%
Nanocomposites
7%
Nitration
6%
Solution
6%
Density
6%
Reversible Addition-Fragmentation Chain Transfer Polymerization
5%
Affinity Chromatography
5%
Differential Scanning Calorimetry
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclodextrin
19%
Liver Fibrosis
14%
High Performance Liquid Chromatography
14%
Nanoparticle Synthesis
10%
Solid Lipid Nanoparticle
9%
Cephalotaxus
9%
Dragon Blood
9%
Pharmacokinetics
9%
Pentobarbital
9%
Bupleurum
9%
Acetonitrile
8%
Antidiabetic Agent
8%
Hyperglycemia
8%
Toll Like Receptor 4
7%
Silicon Dioxide
7%
Diabetes Mellitus
6%
Iridaceae
6%
Polysaccharide
6%
Glycoside
6%
Institute for Cancer Research Mouse
6%
Peroxisome Proliferator Activated Receptor
6%
Wistar Rat
6%
Traditional Chinese Medicine
6%
Bioavailability
6%
Luteolin
6%
Hypolipemia
6%
Triterpenoid Saponin
6%
Diseases
5%
Anti-Inflammatory Drug
5%
Hyperlipidemia
5%
Flavone
5%
